US Patent Issued to University of Maryland, College Park on May 13 for "Compositions and methods for mucosal vaccination against SARS-CoV-2" (Maryland Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,232, issued on May 13, was assigned to University of Maryland, College Park (College Park, Md.).

"Compositions and methods for mucosal vaccination against SARS-CoV-2" was invented by Xiaoping Zhu (Clarksville, Md.), Weizhong Li (College Park, Md.) and Tao Wang (Ellicott City, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are peptides comprising a monomeric Fc fragment of an immunoglobulin recognized by a FcRn; SARS-COV-2 antigen; and a trimerization domain. Disclosed are peptide complexes comprising three peptides, wherein each of the three peptides comprises a monomeric Fc fragment of an immunoglobulin recognized by a FcRn; SARS-COV-...